3476 - 3500 of 6466 Results
Title
Year
- Lower Circulating Lymphocyte Count Predicts ApoEε4‐Related Cognitive Decline in Parkinson's Disease2021OPENTitle: Lower Circulating Lymphocyte Count Predicts ApoEε4‐Related Cognitive Decline in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2969End Page: 2971Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28799Best OA location URL: https://doi.org/10.1002/mds.28799Citation Count: 15
-
OPENTitle: Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 8Start Page: 4195End Page: 4203Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-022-11041-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-022-11041-x.pdfCitation Count: 35
-
OPENTitle: Neurochemical Monitoring of Traumatic Brain Injury by the Combined Analysis of Plasma Beta-Synuclein, NfL, and GFAP in Polytraumatized PatientsJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 17Start Page: 9639End Page: 9639Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms23179639Best OA location URL: https://www.mdpi.com/1422-0067/23/17/9639/pdf?version=1662114737Citation Count: 26
-
OPENTitle: Mitochondrial DNA variation in Parkinson’s disease: Analysis of “out-of-place” population variants as a risk factorJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 921412End Page: 921412Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.921412Best OA location URL: https://doi.org/10.3389/fnagi.2022.921412Citation Count: 18
-
OPENTitle: Targeted copy number variant identification across the neurodegenerative disease spectrumJournal Name: Molecular Genetics & Genomic MedicinePublisher: WileyVol: 10Issue #: 8Start Page: e1986End Page: e1986Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mgg3.1986Best OA location URL: https://doi.org/10.1002/mgg3.1986Citation Count: 8
-
OPENTitle: Elevation of gangliosides in four brain regions from Parkinson’s disease patients with a GBA mutationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 99End Page: 99Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00363-2Best OA location URL: https://www.nature.com/articles/s41531-022-00363-2.pdfCitation Count: 32
-
OPENTitle: Gait‐Related Metabolic Covariance Networks at Rest in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 6Start Page: 1222End Page: 1234Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28977Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28977Citation Count: 23
- Attitudes Toward Telehealth Services Among People Living With Parkinson's Disease: A Survey Study2022OPENTitle: Attitudes Toward Telehealth Services Among People Living With Parkinson's Disease: A Survey StudyJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 6Start Page: 1289End Page: 1294Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28990Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9314606Citation Count: 19
-
OPENTitle: Adenosine A2A Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 853End Page: 857Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28897Best OA location URL: https://doi.org/10.1002/mds.28897Citation Count: 24
- Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment2022OPENTitle: Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive ImpairmentJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 713End Page: 723Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28913Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28913Citation Count: 77
- Differential Phospho‐Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease2022OPENTitle: Differential Phospho‐Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1004End Page: 1015Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28927Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28927Citation Count: 18
-
OPENTitle: Microelectrode Arrays for Simultaneous Electrophysiology and Advanced Optical MicroscopyJournal Name: Advanced SciencePublisher: WileyVol: 8Issue #: 13Start Page: 2004434End Page: 2004434Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/advs.202004434Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202004434Citation Count: 70
-
OPENTitle: Disease Progression in Multiple System Atrophy—Novel Modeling Framework and Predictive FactorsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1719End Page: 1727Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29077Best OA location URL: https://doi.org/10.1002/mds.29077Citation Count: 12
-
OPENTitle: Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathologyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 126End Page: 126Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00397-6Best OA location URL: https://www.nature.com/articles/s41531-022-00397-6.pdfCitation Count: 87
-
OPENTitle: Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 7Start Page: 2541End Page: 2554Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac177Best OA location URL: https://academic.oup.com/brain/article-pdf/145/7/2541/45191149/awac177.pdfCitation Count: 101
-
OPENTitle: Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examinationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 94End Page: 94Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00360-5Best OA location URL: https://www.nature.com/articles/s41531-022-00360-5.pdfCitation Count: 5
-
OPENTitle: Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON TrialJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1409End Page: 1425Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00371-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00371-7.pdfCitation Count: 10
-
OPENTitle: Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome AssessmentJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1319End Page: 1340Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00375-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00375-3.pdfCitation Count: 45
-
OPENTitle: Shared mechanisms across the major psychiatric and neurodegenerative diseasesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 4314End Page: 4314Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-31873-5Best OA location URL: https://escholarship.org/uc/item/23t9767xCitation Count: 191
-
OPENTitle: Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert PanelJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 4Start Page: 1571End Page: 1582Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00388-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00388-y.pdfCitation Count: 11
-
OPENTitle: The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and IIJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page: 994114End Page: 994114Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.994114Best OA location URL: https://doi.org/10.3389/fneur.2022.994114Citation Count: 8
- Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity2022OPENTitle: Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicityJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 25Issue #: 9Start Page: 1134End Page: 1148Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41593-022-01140-3Best OA location URL: https://www.nature.com/articles/s41593-022-01140-3.pdfCitation Count: 253
-
OPENTitle: Systematic Functional Analysis of PINK1 and PRKN Coding VariantsJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 15Start Page: 2426End Page: 2426Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11152426Best OA location URL: https://www.mdpi.com/2073-4409/11/15/2426/pdf?version=1659696395Citation Count: 26
-
OPENTitle: Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 73End Page: 73Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00336-5Best OA location URL: https://www.nature.com/articles/s41531-022-00336-5.pdfCitation Count: 22
- Combining Neuroimaging and Omics Datasets for Disease Classification Using Graph Neural Networks2022OPENTitle: Combining Neuroimaging and Omics Datasets for Disease Classification Using Graph Neural NetworksJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page: 866666End Page: 866666Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.866666Best OA location URL: https://doi.org/10.3389/fnins.2022.866666Citation Count: 40